CCR12P: A Potential Drug Target and Biomarker (G100133168)

CCR12P: A Potential Drug Target and Biomarker

CCR12P (Complement Component 12b) is a protein that is expressed in various tissues throughout the body, including the heart, lungs, kidneys, and intestines. It is a key component of the complement system, which is a group of proteins that work together to help the body fight off infections. In recent years, researchers have discovered that CCR12P plays a crucial role in the regulation of inflammation and immune responses.

Drug Target Potential

The potential drug target for CCR12P is due to its involvement in the complement system and its role in inflammation. Studies have shown that CCR12P is involved in the regulation of the complement activity and that it plays a key role in the production of the C3b molecule, which is a major component of the complement complex that binds to the surface of bacterial cells and triggers the release of enzymes that can destroy pathogens.

Additionally, CCR12P has been shown to be involved in the regulation of pro-inflammatory cytokines, such as TNF-alpha, which are important drivers of inflammation. The balance between pro-inflammatory and anti-inflammatory cytokines is critical for maintaining a healthy immune response. CCR12P has been shown to regulate the production of pro-inflammatory cytokines and to promote the production of anti-inflammatory cytokines, such as IL-10.

Biomarker Potential

CCR12P has also been shown to be a potential biomarker for a variety of diseases, including cardiovascular disease, respiratory tract disease, and inflammatory bowel disease. The levels of CCR12P have been shown to be elevated in individuals with these conditions, and studies have shown that targeting CCR12P with drugs can be effective in reducing inflammation and improving outcomes in these diseases.

CCR12P has also been shown to be a potential biomarker for cancer, as it has been shown to be expressed in various types of cancer, including breast, lung, and colorectal cancer. The levels of CCR12P have been shown to be elevated in individuals with these cancers, and studies have shown that targeting CCR12P with drugs can be effective in reducing cancer growth and improving outcomes in these diseases.

Conclusion

CCR12P is a protein that is involved in the regulation of the complement system and inflammation. Its potential as a drug target is due to its involvement in the regulation of the immune response and its role in the production of pro-inflammatory cytokines. Additionally, CCR12P has also been shown to be a potential biomarker for a variety of diseases, including cardiovascular disease, respiratory tract disease, and inflammatory bowel disease, and has also been shown to be a potential biomarker for cancer. Further research is needed to fully understand the role of CCR12P in these diseases and to develop effective treatments.

Protein Name: C-C Motif Chemokine Receptor 12, Pseudogene

The "CCR12P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCR12P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCR2 | CCR3 | CCR4 | CCR4-NOT transcription complex | CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS | CCSAP | CCSER1 | CCSER2 | CCT2 | CCT3 | CCT4 | CCT5 | CCT6A | CCT6B | CCT6P1 | CCT6P3 | CCT7 | CCT8 | CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53